These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11861963)

  • 1. Recovery from renal failure in malignant hypertension associated with primary aldosteronism: effect of an ACE inhibitor.
    Suzuki H; Asano K; Eiro M; Kuriki M; Hashimoto S; Katoh T; Watanabe T; Watanabe K
    QJM; 2002 Feb; 95(2):128-30. PubMed ID: 11861963
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure induced by angiotensin converting enzyme inhibitor in a patient with polyarteritis nodosa.
    Wang AY; Lai KN; Li PK; Leung CB; Lui SF
    Ren Fail; 1996 Mar; 18(2):293-8. PubMed ID: 8723367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature.
    Logee KM; Lakshminarayanan S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S171-4. PubMed ID: 25797912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omapatrilat.
    Armstrong PW; Lorell BH; Nissen S; Borer J
    Circulation; 2002 Aug; 106(6):e9011-2. PubMed ID: 12187916
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new class of potent antihypertensive agents. Especially systolic pressure is significantly reduced].
    MMW Fortschr Med; 1999 Nov; 141(47):8. PubMed ID: 10912157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasopeptidase inhibition: a new mechanism of action--a new antihypertensive drug].
    Waeber B
    Praxis (Bern 1994); 2000 Apr; 89(16):649-53. PubMed ID: 10823018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Omapatrilat--new drug for patients with hypertension and heart failure].
    Dzielska-Olczak M
    Pol Merkur Lekarski; 2005 Oct; 19(112):556-8. PubMed ID: 16379325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite low plasma renin ACE inhibitor treatment causes recovery from acute renal failure in a patient with malignant hypertension.
    Watanabe T; Yonemura K; Fujigaki Y; Suzuki T; Motomura E; Sano K; Ikegaya N; Yamamoto T; Kimura M; Hishida A; Kaneko E
    Nephrol Dial Transplant; 1998 Mar; 13(3):769-72. PubMed ID: 9550666
    [No Abstract]   [Full Text] [Related]  

  • 10. Page kidney: taking a page from history.
    Wahdat R; Schwartz C; Espinosa J; Lucerna A
    Am J Emerg Med; 2017 Jan; 35(1):193.e1-193.e2. PubMed ID: 27439385
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of omapatrilat in low, normal, and high renin experimental hypertension.
    Trippodo NC; Robl JA; Asaad MM; Fox M; Panchal BC; Schaeffer TR
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):363-72. PubMed ID: 9544878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Omapatrilat for treatment of heart failure].
    Yamazaki T
    Nihon Rinsho; 2007 May; 65 Suppl 5():173-5. PubMed ID: 17571381
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
    Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
    Horino T; Ito H; Tanimoto N; Yoshida T; Sasaoka A; Chijiwa T; Hosokawa T; Hashimoto K
    Nihon Jinzo Gakkai Shi; 2003; 45(2):104-8. PubMed ID: 12703406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma renal crisis.
    Steen V
    Indian J Med Sci; 2007 Feb; 61(2):71-2. PubMed ID: 17259685
    [No Abstract]   [Full Text] [Related]  

  • 16. Scleroderma renal crisis.
    Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
    J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
    Kirichenko AA; Ebzeeva EIu
    Kardiologiia; 2002; 42(10):36-40. PubMed ID: 12494055
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of malignant hypertension in a young woman.
    Michelli A; Bernardi S; Grillo A; Panizon E; Rovina M; Bardelli M; Carretta R; Fabris B
    BMC Nephrol; 2016 Jul; 17(1):65. PubMed ID: 27389397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma renal crisis.
    Hudson M; Ghossein C; Steen V
    Presse Med; 2021 Apr; 50(1):104063. PubMed ID: 33548376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.